Bioceres Crop Solutions (NASDAQ:BIOX) Announces Earnings Results, Misses Estimates By $0.11 EPS

Bioceres Crop Solutions (NASDAQ:BIOX) posted its quarterly earnings data on Monday. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of ($0.05) by ($0.11), Zacks reports. Bioceres Crop Solutions had a negative return on equity of 29.01% and a negative net margin of 92.85%.The business had revenue of $39.40 million for the quarter, compared to the consensus estimate of $54.50 million.

Bioceres Crop Solutions Price Performance

NASDAQ BIOX opened at $0.45 on Wednesday. The stock has a 50-day moving average of $0.51 and a 200 day moving average of $1.02. Bioceres Crop Solutions has a one year low of $0.35 and a one year high of $5.18. The company has a market capitalization of $28.52 million, a price-to-earnings ratio of -0.12 and a beta of 0.39. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.69 and a current ratio of 0.90.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on BIOX shares. Weiss Ratings downgraded shares of Bioceres Crop Solutions from a “sell (d)” rating to a “sell (d-)” rating in a research note on Wednesday, May 6th. Wall Street Zen cut Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a research report on Saturday, April 4th. One investment analyst has rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $4.00.

Institutional Trading of Bioceres Crop Solutions

A number of hedge funds have recently bought and sold shares of the company. GAM Holding AG purchased a new stake in Bioceres Crop Solutions in the 4th quarter worth approximately $655,000. Marshall Wace LLP lifted its holdings in Bioceres Crop Solutions by 180.0% during the fourth quarter. Marshall Wace LLP now owns 595,410 shares of the company’s stock valued at $780,000 after purchasing an additional 382,744 shares in the last quarter. Susquehanna International Group LLP purchased a new position in Bioceres Crop Solutions during the third quarter valued at approximately $315,000. State of Wisconsin Investment Board bought a new position in shares of Bioceres Crop Solutions in the fourth quarter worth approximately $247,000. Finally, Squarepoint Ops LLC purchased a new stake in shares of Bioceres Crop Solutions in the third quarter worth $233,000. Hedge funds and other institutional investors own 17.68% of the company’s stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.